Quantcast

Global Cardiac Bio Implant Devices (Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device)

October 29, 2013

Reportbuyer.com just published a new market research report: Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A.

London (PRWEB) October 29, 2013

The cardiac implant medical device market is forecasted to grow in single digit percent per year during 2010-2017 and is likely to exceed US$ 27 Billion by 2017. Growth in this sector is anticipated to grow despite continuing product recalls and safety controversies, particularly in the Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers segment. Product innovation, together with demographic structure of the world population, will play a pivotal role in the future growth of the market. Additionally, developing healthcare sector and advanced infrastructure along with infusion of new professional skills and expertise in emerging economies continue to propel long-term growth opportunities for manufacturers operating in the market.

Renub Research study titled “Global Cardiac Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A” provides a comprehensive assessment of the fast-evolving, high-growth global cardiac implant market. This 284 page report with 258 Figures and 24 Tables studies the Global Cardiac Implant Device Market. This report contains 24 chapters and has been bifurcate into 10 segments.

i) Worldwide Cardiac Implants Device Analysis (Chapter 2)

ii) Implantable Cardioverter Defibrillators (ICD) (Chapter 3 to 5)

iii) Implantable Cardiac Pacemakers (ICP) (Chapter 6 to 8)

iv) Heart Valve (Chapter 9 to 11)

v) Coronary Stent (Chapter 12 to 15)

vi) Perpheral Stent (Chapter 16 to 17)

vii) Ventricular Assist Device (Chapter 18 to 20)

viii) Cardiac Implants Devices Clinical Trial Statement (Chapter 21)

ix) Merger & Acquisitions (Chapter 22)

x) Growth Drivers & Challenges (Chapter 22 to 24)

All the above segments have been further sub divided into

a) Market & Forecast (2008 – 2017)

b) Sales Unit & Forecast (By Volume) (2008 – 2017)

c) Market Share & Forecast (2008 – 2017)

d) Companies Market Share & Forecast(2008 – 2017)

e) Companies Revenue & Forecast (2008 – 2017)

f) Clinical Trial Statement

g) Merger & Acquisition

h) Growth Driver & Challenges

The Following 24 Chapters Contains

•First chapter is Executive Summary.

•Second chapter contains worldwide cardiac implants device market, market share & forecast (2010 – 2017).

•Third to Fifth chapter contains implantable cardioverter defibrillators (ICD) (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2008 – 2017).

•Sixth to Eighth chapter contains implantable cardiac pacemakers (ICP) (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2008 – 2017).

•Ninth to Eleventh chapter contains heart valve (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2009-2017).

•Twelfth to Fifteenth chapter contains coronary stent (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2008-2017).

•Sixteenth to Seventeenth chapter contains peripheral stent (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2010-2017).

•Eighteenth to nineteenth chapter contains ventricular assist device (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2010-2017).

•Twentieth to Twenty Three chapters contains clinical trial statement, merger & acquisition, growth driver & challenges.

Company Analysis (By Segment) – Revenue & Forecast

Implantable Cardioverter Defibrillators (ICD): Boston Scientific, St Jude Medical, Medtronic & Others

Implantable Cardiac Pacemakers (ICP): Medtronic, Boston Scientific, St Jude Medical, & Others

Heart Valve: Edwards Lifesciences, Medtronic, St. Jude Medical, Sorin Group & Others

Coronary Stent: Abbott Laboratories, Boston Scientific, Medtronic, Cordis Corporation (Johnson & Johnson), Others

Geographic Region (By Countries) – Market, Sales Unit (Volume) & Forecast

Implantable Cardioverter Defibrillators (ICD): Worldwide, United States & Rest of the World (ROW)

Implantable Cardiac Pacemakers (ICP): Worldwide, United States & Rest of the World (ROW)

Heart Valve: Worldwide

Coronary Stent (Drug Eluting Stent & Bare Metal Stent): Worldwide, United States, Japan, Europe & Rest of the World (ROW)

Peripheral Stent: Worldwide

Ventricular Assist Device: Worldwide, United States & Rest of World (ROW)

Clinical Trail Analysis – By Company

Edwards Lifesciences, St. Jude Medical, Boston Scientific , Medtronic, Sorin Group, Abbott Laboratories

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Table of Contents

1. Executive Summary

2. Worldwide Cardiac Implants Device Analysis (2010 – 2017)

2.1 Worldwide – Cardiac Implants Device Market & Forecast

2.2 Worldwide – Cardiac Implants Device Market Share & Forecast

3. Implantable Cardioverter Defibrillators (ICD) Analysis (2008 – 2017)

3.1 Worldwide – ICD Market & Forecast

3.2 Worldwide – ICD Sales Unit & Forecast (By Volume)

3.3 USA vs. Rest of World – ICD Market Share & Forecast

3.4 Companies (Boston Scientific, St Jude Medical, Medtronic & Others) – ICD Market Share & Forecast

4. Implantable Cardioverter Defibrillators (ICD) Market, Volume & Forecast – USA & ROW (2008 – 2017)

4.1 United States – ICD Market & Forecast

4.2 United States – ICD Sales Unit & Forecast (By Volume)

4.3 Rest of the World (ROW) – ICD Market & Forecast

4.4 Rest of the World (ROW) – ICD Sales Unit & Forecast (By Volume)

5. Implantable Cardioverter Defibrillators (ICD) Revenue & Forecast – Companies Analysis (2008 – 2017)

5.1 Boston Scientific Implantable Cardioverter Defibrillators (ICD) Revenue & Forecast

5.1.1 Worldwide – Boston Scientific ICD Revenue & Forecast

5.1.2 United States – Boston Scientific ICD Revenue & Forecast

5.1.3 Rest of the World – Boston Scientific ICD Revenue & Forecast

5.2 St Jude Medical Implantable Cardioverter Defibrillators (ICD) Revenue & Forecast

5.2.1 Worldwide – St Jude Medical ICD Revenue & Forecast

5.2.2 United States – St Jude Medical ICD Revenue & Forecast

5.2.3 Rest of the World – St Jude Medical ICD Revenue & Forecast

5.3 Medtronic Implantable Cardioverter Defibrillators (ICD) Revenue & Forecast

5.3.1 Worldwide – Medtronic ICD Revenue & Forecast

5.3.2 United States – Medtronic ICD Revenue & Forecast

5.3.3 Rest of the World – Medtronic ICD Revenue & Forecast

5.4 Other Companies Implantable Cardioverter Defibrillators (ICD) Revenue & Forecast

5.4.1 Worldwide – Other Companies ICD Revenue & Forecast

5.4.2 United States – Other Companies ICD Revenue & Forecast

5.4.3 Rest of the World – Other Companies ICD Revenue & Forecast

6. Implantable Cardiac Pacemakers (ICP) Analysis (2008 – 2017)

6.1 Worldwide – ICP Market & Forecast

6.2 Worldwide – ICP Sales Unit & Forecast (By Volume)

6.3 USA vs. Rest of World – ICP Market Share & Forecast

6.4 Companies (Medtronic, Boston Scientific, St Jude Medical & Others) – ICP Market Share & Forecast

7. Implantable Cardiac Pacemakers (ICP) Market, Volume & Forecast (2008 – 2017)

7.1 United States – ICP Market & Forecast

7.2 United States – ICP Sales Unit & Forecast (By Volume)

7.3 Rest of the World (ROW) – ICP Market & Forecast

7.4 Rest of the World (ROW) – ICP Sales Unit & Forecast (By Volume)

8. Implantable Cardiac Pacemakers (ICP) Revenue & Forecast – Companies Analysis (2008 – 2017)

8.1 Medtronic Implantable Cardiac Pacemakers (ICP) Revenue & Forecast

8.1.1 Worldwide – Medtronic ICP Revenue & Forecast

8.1.2 United States – Medtronic ICP Revenue & Forecast

8.1.3 Rest of the World – Medtronic ICP Revenue & Forecast

8.2 Boston Scientific Implantable Cardiac Pacemakers Revenue & Forecast

8.2.1 Worldwide – Boston Scientific ICP Revenue & Forecast

8.2.2 United States – Boston Scientific ICP Revenue & Forecast

8.2.3 Rest of the World – Boston Scientific ICP Revenue & Forecast

8.3 St Jude Medical Implantable Cardiac Pacemakers Revenue & Forecast

8.3.1 Worldwide – St Jude Medical ICP Revenue & Forecast

8.3.2 United States – St Jude Medical IPC Revenue & Forecast

8.3.3 Rest of the World – St Jude Medical ICP Revenue & Forecast

8.4 Other Companies ICP Revenue & Forecast

8.4.1 Worldwide – Other Companies ICP Revenue & Forecast

8.4.2 United States – Other Companies ICP Revenue & Forecast

8.4.3 Rest of the World – Other Companies ICP Revenue & Forecast

9. Heart Valve Analysis (2009 – 2017)

9.1 Worldwide – Heart Valve Market & Forecast

9.2 Worldwide – Heart Valve Sales Unit & Forecast (By Volume)

9.3 By Application – Heart Valve Market Share & Forecast

9.4 Companies (Edwards Lifesciences, Medtronic, St. Jude Medical, Sorin Group & Others) – Heart Valve Market Share & Forecast

10. By Application (Worldwide) – Heart Valve Market, Volume & Forecast (2009 – 2017)

10.1 Transcatheter Heart Valve Market & Forecast

10.1.1 US FDA Approval of Sapien Transcatheter Heart Valve (THV)

10.1.2 Competition Set to Increase with Pipeline of THV

10.1.3 Technological Advances in THVR

10.1.4 Favorable Reimbursement in Europe

10.2 Transcatheter Heart Valve Sales Unit & Forecast (By Volume)

10.3 Tissue Heart Valve Market & Forecast

10.4 Tissue Heart Valve Sales Unit & Forecast (By Volume)

10.5 Mechanical Heart Valve Market & Forecast

10.6 Mechanical Heart Valve Sales Unit & Forecast (By Volume)

10.7 Repair Heart Valve Market & Forecast

10.8 Repair Heart Valve Sales Unit & Forecast (By Volume)

10.9 Perceval Sutureless Heart Valve Market & Forecast

10.10 Perceval Sutureless Heart Valve Sales Unit & Forecast (By Volume)

11. Heart Valve Revenue & Forecast – Companies Analysis (2009 – 2017)

11.1 Worldwide – Edwards Lifesciences Heart Valve Revenue & Forecast

11.2 Worldwide – Medtronic Heart Valve Revenue & Forecast

11.3 Worldwide – St. Jude Medical Heart Valve Revenue & Forecast

11.4 Worldwide – Sorin Group Heart Valve Revenue & Forecast

11.5 Worldwide – Other Companies Heart Valve Revenue & Forecast

12. Coronary Stent Analysis (2008 – 2017)

12.1 Worldwide – Coronary Stent Market & Forecast

12.2 Worldwide – Coronary Stent Sales Unit – By Volume

12.3 Countries (US, Japan, Europe & ROW) – Coronary Stent Market Share & Forecast

12.4 By Application – Coronary Stent Market Share & Forecast

12.5 Companies (Abbott Laboratories, Boston Scientific, Medtronic, Cordis Corporation) – Coronary Stent Market Share & Forecast

13. Countries – Coronary Stent Market & Forecast (2008 – 2017)

13.1 United States – Coronary Stent Market & Forecast

13.2 United States – Coronary Stent Sales Unit & Forecast (By Volume)

13.3 Europe & Rest of the World (ROW) – Coronary Stent Market & Forecast

13.4 Europe & Rest of the World (ROW) – Coronary Stent Sales Unit (By Volume)

13.5 Japan – Coronary Stent Market & Forecast

13.6 Japan – Coronary Stent Sales Unit & Forecast (By Volume)

14. By Application (Drug Eluting Stent & Bare Metal Stent) – Coronary Stent Analysis (2008 – 2017)

14.1 Worldwide – Drug Eluting Stent Market & Forecast

14.1.1 United States – Drug Eluting Stent Market & Forecast

14.1.2 Europe & Rest of the World – Drug Eluting Stent Market & Forecast

14.1.3 Japan – Drug Eluting Stent Market & Forecast

14.2 Worldwide – Drug Eluting Stent Sales Unit & Forecast (By Volume)

14.2.1 United States – Drug Eluting Stent Sales Unit & Forecast (By Volume)

14.2.2 Europe & Rest of the World – Drug Eluting Stent Sales Unit & Forecast (By Volume)

14.2.3 Japan – Drug Eluting Stent Sales Unit & Forecast (By Volume)

14.3 Worldwide – Bare Metal Stent Market & Forecast

14.3.1 United States – Bare Metal Stent Market & Forecast

14.3.2 Europe & Rest of the World – Bare Metal Stent Market & Forecast

14.3.3 Japan – Bare Metal Stent Market & Forecast

14.4 Worldwide – Bare Metal Stent Sales Unit & Forecast (By Volume)

14.4.1 United States – Bare Metal Stent Sales Unit & Forecast (By Volume)

14.4.2 Europe & Rest of the World – Bare Metal Stent Sales Unit & Forecast (By Volume)

14.4.3 Japan – Bare Metal Stent Sales Unit & Forecast (By Volume)

15. Companies – Coronary Stent Revenue & Forecast (2008 – 2017)

15.1 Worldwide – Abbott Laboratories Coronary Stent Revenue & Forecast

15.1.1 United States – Abbott Laboratories Coronary Stent Revenue & Forecast

15.1.2 Europe & Rest of the World – Abbott Laboratories Coronary Stent Revenue & Forecast

15.1.3 Japan – Abbott Laboratories Coronary Stent Revenue & Forecast

15.2 Boston Scientific Coronary Stent Revenue & Forecast

15.2.1 Worldwide – Boston Scientific Coronary Stent Revenue & Forecast

15.2.2 United States – Boston Scientific Coronary Stent Revenue & Forecast

15.2.3 Europe & Rest of the World – Boston Scientific Coronary Stent Revenue & Forecast

15.2.4 Japan – Boston Scientific Coronary Stent Revenue & Forecast

15.3 Medtronic Coronary Stent Revenue & Forecast

15.3.1 Worldwide – Medtronic Coronary Stent Revenue & Forecast

15.3.2 United States – Medtronic Coronary Stent Revenue & Forecast

15.3.3 Europe & ROW – Medtronic Coronary Stent Revenue & Forecast

15.3.4 Japan – Medtronic Coronary Stent Revenue & Forecast

15.4 Cordis Corporation (Johnson & Johnson) Stent Revenue & Forecast

15.4.1 Worldwide – Cordis Corporation Coronary Stent Revenue & Forecast

15.4.2 United States – Cordis Corporation Coronary Stent Revenue

15.4.3 Europe & Rest of the World – Cordis Corporation Coronary Stent Revenue

15.4.4 Japan – Cordis Corporation Coronary Stent Revenue

15.5 Other Companies Coronary Stent Revenue & Forecast

15.5.1 Worldwide – Other Companies Coronary Stent Revenue & Forecast

15.5.2 United States – Other Companies Coronary Stent Revenue & Forecast

15.5.3 Europe & Rest of the World – Other Companies Coronary Stent Revenue & Forecast

15.5.3.1 Japan – Other Companies Coronary Stent Revenue & Forecast

16. Peripheral Stent Analysis (2010 – 2017)

16.1 Worldwide – Peripheral Stent Market & Forecast

16.2 Worldwide – Peripheral Stent Sales Unit & Forecast (By Volume)

16.3 Worldwide – Peripheral Stent Market Share & Forecast

17. By Application – Peripheral Stent Market, Sales Unit & Forecast (2010 – 2017)

17.1 Worldwide – Endovascular Stent Graft Market & Forecast

17.2 Worldwide – Endovascular Stent Graft Sales Unit & Forecast (By Volume)

17.3 Worldwide – Carotid Stent Market & Forecast

17.4 Worldwide – Carotid Stent Sales Unit & Forecast (By Volume)

17.5 Worldwide – Renal & Related Stent Market & Forecast

17.6 Worldwide – Renal & Related Stent Sales Unit & Forecast (By Volume)

17.7 Worldwide – Femoral & Related Stent Market & Forecast

17.8 Worldwide – Femoral & Related Stent Sales Unit & Forecast (By Volume)

18. Ventricular Assist Device Analysis (2010 – 2017)

18.1 Worldwide – Ventricular Assist Device Market & Forecast

18.2 Worldwide – Ventricular Assist Device Sales Unit & Forecast (By Volume)

18.3 By Countries – Ventricular Assist Device Market Share & Forecast

18.4 By Application – Ventricular Assist Device Market Share & Forecast

19. Countries – Ventricular Assist Device Market & Forecast (2010 – 2017)

19.1 United States – Ventricular Assist Device Market

19.2 United States – Ventricular Assist Device Sales Unit & Forecast (By Volume)

19.3 Rest of the World – Ventricular Assist Device Market & Forecast

19.4 Rest of the World – Ventricular Assist Device Sales Unit & Forecast (By Volume)

20. By Application – Ventricular Assist Device Market & Forecast (2010 – 2017)

20.1 Worldwide – Left Ventricular Assist Device Market & Forecast

20.2 Worldwide – Left Ventricular Assist Device Sales Unit & Forecast (By Volume)

20.3 Worldwide – Other VAD Devices (Right VAD, Bi VAD & External VAD) Market & Forecast

20.4 Worldwide – Other VAD Devices (Right VAD, Bi VAD & External VAD) Sales Unit & Forecast (By Volume)

21. Companies Pipeline Cardiac Implants Devices Clinical Trial Statement

21.1 Edwards Lifesciences

21.1.1 The Partner Trial: Placement of Aortic Transcatheter Valve Trial

21.1.2 The Partner II Trial: Placement of Aortic Transcatheter Valves Trial

21.2 St. Jude Medical

21.2.1 Risk Stratification & Benefits with Cardiac Resynchronization Therapy (CRT)

21.2.2 Comparison between Fractional Flow Reserve (FFR) Guided Revascularization versus Conventional Strategy in Acute ST-elevation Myocardial Infarction (STEMI) Patients with Multivessel Coronary Disease

21.2.3 FAME II – Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) plus Optimal Medical Treatment (OMT) verses Optimal Medical Treatment OMT Alone in Patients with Stable Coronary Artery Disease

21.3 Boston Scientific

21.3.1 Prevent: Promus BTK

21.3.2 Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT) Post Approval Registry

21.3.3 Supernova Clinical Stenting Trial

21.3.4 Comparison of Biolimus-eluting Biodegradable Polymer, Everolimus-eluting and Sirolimus-eluting Coronary Stents (BESS)

21.4 Medtronic

21.4.1 Safety and Efficacy Study of the Medtronic CoreValve System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement

21.4.2 Utility of the Audible Alert in Current Generation Medtronic Implantable Cardioverter-defibrillators

21.4.3 Transapical Implantation of the Medtronic Engager Transcatheter Aortic Valve Implantation System – The Engager European Pivotal Trial

21.4.4 Adenosine Testing to Determine the Need for Pacing Therapy (ADEPT-ILR)

21.4.5 Resolute Integrity US (RI-US)

21.5 Sorin Group

21.5.1 Efficacy of the ATP Switch Automatic Programming in Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronization Therapy Defibrillator (CRT-D) Implanted Patients

21.5.2 Safety & Effectiveness Study of Perceval S Valve for Extended CE Mark (CAVALIER)

21.5.3 Freedom SOLO Stentless Heart Valve

21.5.4 Acute Optimization of Cardiac Resynchronization Therapy (CRT) Using Echocardiography and SonR (SonR Access)

21.6 Abbott Laboratories

21.6.1 Hybrid Sirolimus-Eluting Versus Everolimus-Eluting Stents for Total Coronary Occlusions (PRISON-IV)

21.6.2 Study of the Orsiro Drug Eluting Stent System (BIOFLOW-II)

22. Merger & Acquisitions in Global Cardiac Implants Market

23. Growth Driver of Cardiac Implants Devices Market

23.1 Habits Influencing the Cardiac Implants Devices Market

23.2 Urbanization and Cardiovascular Diseases

23.3 Innovation in Implantable Cardiac Devices Bolster Cardiac Implant Market

24. Challenges of Cardiac Implants Devices Market

24.1 Significance of Cardiovascular Device Innovation

24.2 Regulation

List of Tables:

Table 21 1: Clinical Trial – The Partner Trial: Placement of Aortic Transcatheter Valve Trial

Table 21 2: Clinical Trial – The Partner II Trial: Placement of Aortic Transcatheter Valve Trial

Table 21 3: Clinical Trial – Risk Stratification & Benefits with Cardiac Resynchronization Therapy (CRT)

Table 21 4: Clinical Trial – Comparison between FFR Guided Revascularization versus Conventional Strategy in Acute STEMI Patients with MVD

Table 21 5: Clinical Trial – FAME II – FFR Guided PCI plus Optimal Medical Treatment (OMT) verses OMT Alone in Patients with Stable Coronary Artery Disease

Table 21 6: Clinical Trial – Prevent: Promus BTK

Table 21 7: Clinical Trial – Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT) Post Approval Registry

Table 21 8: Clinical Trial – Supernova Clinical Stenting Trial

Table 21 9: Clinical Trial – Comparison of Biolimus-eluting Biodegradable Polymer, Everolimus-eluting and Sirolimus-eluting Coronary Stents (BESS)

Table 21 10: Clinical Trial – Safety and Efficacy Continued Access Study of the Medtronic CoreValve System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement

Table 21 11: Clinical Trial – Utility of the Audible Alert in Current Generation Medtronic Implantable Cardioverter-defibrillators

Table 21 12: Clinical Trial – Transapical Implantation of the Medtronic Engager Transcatheter Aortic Valve Implantation System – The Engager European Pivotal Trial

Table 21 13: Clinical Trial – Adenosine Testing to Determine the Need for Pacing Therapy (ADEPT-ILR)

Table 21 14: Clinical Trial – Resolute Integrity US (RI-US)

Table 21 15: Clinical Trial – Efficacy of the ATP Switch Automatic Programming in Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronization Therapy Defibrillator (CRT-D) Implanted Patients

Table 21 16: Clinical Trial – Safety & Effectiveness Study of Perceval S Valve for Extended CE Mark (CAVALIER)

Table 21 17: Clinical Trial – Freedom SOLO Stentless Heart Valve

Table 21 18: Clinical Trial – Acute Optimization of Cardiac Resynchronization Therapy (CRT)Using Echocardiography and SonR (SonR Access)

Table 21 19: Clinical Trial – Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions (PRISON-IV)

Table 21 20: Clinical Trial – Study of the Orsiro Drug Eluting Stent System

Table 22 1: Worldwide – Merger & Acquisitions in Cardiac Implants Market (Million US$), 2000 – 2012

Table 23 1: United States – Obese Among Various Demographic Groups (Percent), 2008 – 2012

Table 23 2: United States – Annual Deaths & estimates of smoking attributable mortality (SAM), years of potentials life lost (YPLL) & productivity losses, by sex & cause of death, Male (2000 – 2004)

Table 23 3: United States – Annual Deaths & estimates of smoking attributable mortality (SAM), years of potentials life lost (YPLL) & productivity losses, by sex & cause of death, Female (2000 – 2004)

List of Figures:

Figure 2 1: Worldwide – Cardiac Implants Device Market (Million US$), 2010 – 2012

Figure 2 2: Worldwide – Forecast for Cardiac Implants Device Market (Million US$), 2013 – 2017

Figure 2 3: Worldwide – Cardiac Implants Device Market Share (Percent), 2010 – 2012

Figure 2 4: Worldwide – Forecast for Cardiac Implants Device Market Share (Percent), 2013 – 2017

Figure 3 1: Worldwide – Implantable Cardioverter Defibrillators Market (Million US$), 2008 – 2012

Figure 3 2: Worldwide – Forecast for Implantable Cardioverter Defibrillators Market (Million US$), 2013 – 2017

Figure 3 3: Worldwide – Implantable Cardioverter Defibrillators (ICD) Sales Unit (Thousand), 2008 – 2012

Figure 3 4: Worldwide – Forecast for Implantable Cardioverter Defibrillators (ICD) Sales Unit (Thousand), 2013 – 2017

Figure 3 5: Worldwide – Countries wise Implantable Cardioverter Defibrillators (ICD) Market Share (Percent), 2008 – 2012

Figure 3 6: Worldwide – Forecast for Countries wise Implantable Cardioverter Defibrillators (ICD) Market Share (Percent), 2013 – 2017

Figure 3 7: Worldwide – Companies Wise Implantable Cardioverter Defibrillators (ICD) Market Share (Percent), 2008 – 2012

Figure 3 8: Worldwide – Forecast for Companies Wise Implantable Cardioverter Defibrillators (ICD) Market Share (Percent), 2013 – 2017

Figure 4 1: United States – Implantable Cardioverter Defibrillators Market (Million US$), 2008 – 2012

Figure 4 2: United States – Forecast for Implantable Cardioverter Defibrillators Market (Million US$), 2013 – 2017

Figure 4 3: United States – Implantable Cardioverter Defibrillators (ICD) Sales Unit (Thousand), 2008 – 2012

Figure 4 4: United States – Forecast for Implantable Cardioverter Defibrillators (ICD) Sales Unit (Thousand), 2013 – 2017

Figure 4 5: Rest of the World – Implantable Cardioverter Defibrillators Market (Million US$), 2008 – 2012

Figure 4 6: Rest of the World – Forecast for Implantable Cardioverter Defibrillators Market (Million US$), 2013 – 2017

Figure 4 7: Rest of the World – Implantable Cardioverter Defibrillators (ICD) Sales Unit (Thousand), 2008 – 2012

Figure 4 8: Rest of the World – Forecast for Implantable Cardioverter Defibrillators (ICD) Sales Unit (Thousand), 2013 – 2017

Figure 5 1: Worldwide – Boston Scientific Implantable Cardioverter Defibrillators (ICD) Revenue (Million US$), 2008 – 2012

Figure 5 2: Worldwide – Forecast for Boston Scientific Implantable Cardioverter Defibrillators (ICD) Revenue (Million US$), 2013 – 2017

Figure 5 3: United States – Boston Scientific Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 – 2012

Figure 5 4: United States – Forecast for Boston Scientific Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 – 2017

Figure 5 5: Rest of the World – Boston Scientific Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 – 2012

Figure 5 6: Rest of the World – Forecast for Boston Scientific Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 – 2017

Figure 5 7: Worldwide – St Jude Medical Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 – 2012

Figure 5 8: Worldwide – Forecast for St Jude Medical Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 – 2017

Figure 5 9: United States – St Jude Medical Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 – 2012

Figure 5 10: United States – Forecast for St Jude Medical Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 – 2017

Figure 5 11: Rest of the World – St Jude Medical Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 – 2012

Figure 5 12: Rest of the World – Forecast for St Jude Medical Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 – 2017

Figure 5 13: Worldwide – Medtronic Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 – 2012

Figure 5 14: Worldwide – Forecast for Medtronic Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 – 2017

Figure 5 15: United States – Medtronic Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 – 2012

Figure 5 16: United States – Forecast for Medtronic Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 – 2017

Figure 5 17: Rest of the World – Medtronic Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 – 2012

Figure 5 18: Rest of the World – Forecast for Medtronic Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 – 2017

Figure 5 19: Worldwide – Other Companies Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 – 2012

Figure 5 20: Worldwide – Forecast for Other Companies Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 – 2017

Figure 5 21: United States – Other Companies Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 – 2012

Figure 5 22: United States – Forecast for Other Companies Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 – 2017

Figure 5 23: Rest of the World – Other Companies Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 – 2012

Figure 5 24: Rest of the World – Forecast for Other Companies Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 – 2017

Figure 6 1: Worldwide – Implantable Cardiac Pacemakers (ICP) Market (Million US$), 2008 – 2012

Figure 6 2: Worldwide – Forecast for Implantable Cardiac Pacemakers Market (Million US$), 2013 – 2017

Figure 6 3: Worldwide – Implantable Cardiac Pacemakers (ICP) Sales Unit (Thousand), 2008 – 2012

Figure 6 4: Worldwide – Forecast for Implantable Cardiac Pacemakers (ICP) Sales Unit (Thousand), 2013 – 2017

Figure 6 5: Worldwide – Countries wise Implantable Cardiac Pacemakers (ICP) Market Share (Percent), 2008 – 2012

Figure 6 6: Worldwide – Forecast for Countries wise Implantable Cardiac Pacemakers (ICP) Market Share (Percent), 2013 – 2017

Figure 6 7: Worldwide – Companies wise Implantable Cardiac Pacemakers (ICP) Market Share (Percent), 2008 – 2012

Figure 6 8: Worldwide – Forecast for Companies wise Implantable Cardiac Pacemakers (ICP) Market Share (Percent), 2013 – 2017

Figure 7 1: United States – Implantable Cardiac Pacemakers Market (Million US$), 2008 – 2012

Figure 7 2: United States – Forecast for Implantable Cardiac Pacemakers Market (Million US$), 2013 – 2017

Figure 7 3: United States – Implantable Cardiac Pacemakers (ICP) Sales Unit (Thousand), 2008 – 2012

Figure 7 4: United States – Forecast for Implantable Cardiac Pacemakers (ICP) Sales Unit (Thousand), 2013 – 2017

Figure 7 5: Rest of the World – Implantable Cardiac Pacemakers Market (Million US$), 2008 – 2012

Figure 7 6: Rest of the World – Forecast for Implantable Cardiac Pacemakers Market (Million US$), 2013 – 2017

Figure 7 7: Rest of the World – Implantable Cardiac Pacemakers (ICP) Sales Unit (Thousand), 2008 – 2012

Figure 7 8: Rest of the World – Forecast for Implantable Cardiac Pacemakers (ICP) Sales Unit (Thousand), 2013 – 2017

Figure 8 1: Worldwide – Medtronic Implantable Cardiac Pacemakers Revenue (Million US$), 2008 – 2012

Figure 8 2: Worldwide – Forecast for Medtronic Implantable Cardiac Pacemakers Revenue (Million US$), 2013 – 2017

Figure 8 3: United States – Medtronic Implantable Cardiac Pacemakers Revenue (Million US$), 2008 – 2012

Figure 8 4: United States – Forecast for Medtronic Implantable Cardiac Pacemakers Revenue (Million US$), 2013 – 2017

Figure 8 5: Rest of the World – Medtronic Implantable Cardiac Pacemakers Revenue (Million US$), 2008 – 2012

Figure 8 6: Rest of the World – Forecast for Medtronic Implantable Cardiac Pacemakers Revenue (Million US$), 2013 – 2017

Figure 8 7: Worldwide – Boston Scientific Implantable Cardiac Pacemakers Revenue (Million US$), 2008 – 2012

Figure 8 8: Worldwide – Forecast for Boston Scientific Implantable Cardiac Pacemakers Revenue (Million US$), 2013 – 2017

Figure 8 9: United States – Boston Scientific Implantable Cardiac Pacemakers Revenue (Million US$), 2008 – 2012

Figure 8 10: United States – Forecast for Boston Scientific Implantable Cardiac Pacemakers Revenue (Million US$), 2013 – 2017

Figure 8 11: Rest of the World – Boston Scientific Implantable Cardiac Pacemakers Revenue (Million US$), 2008 – 2012

Figure 8 12: Rest of the World – Forecast for Boston Scientific Implantable Cardiac Pacemakers Revenue (Million US$), 2013 – 2017

Figure 8 13: Worldwide – St Jude Medical Implantable Cardiac Pacemakers Revenue (Million US$), 2008 – 2012

Figure 8 14: Worldwide – Forecast for St Jude Medical Implantable Cardiac Pacemakers Revenue (Million US$), 2013 – 2017

Figure 8 15: United States – St Jude Medical Implantable Cardiac Pacemakers Revenue (Million US$), 2008 – 2012

Figure 8 16: United States – Forecast for St Jude Medical Implantable Cardiac Pacemakers Revenue (Million US$), 2013 – 2017

Figure 8 17: Rest of the World – St Jude Medical Implantable Cardiac Pacemakers Revenue (Million US$), 2008 – 2012

Figure 8 18: Rest of the World – Forecast for St Jude Medical Implantable Cardiac Pacemakers Revenue (Million US$), 2013 – 2017

Figure 8 19: Worldwide – Other Companies Implantable Cardiac Pacemakers Revenue (Million US$), 2008 – 2012

Figure 8 20: Worldwide – Forecast for Other Companies Implantable Cardiac Pacemakers Revenue (Million US$), 2013 – 2017

Figure 8 21: United States – Other Companies Implantable Cardiac Pacemakers Revenue (Million US$), 2008 – 2012

Figure 8 22: United States – Forecast for Other Companies Implantable Cardiac Pacemakers Revenue (Million US$), 2013 – 2017

Figure 8 23: Rest of the World – Other Companies Implantable Cardiac Pacemakers Revenue (Million US$), 2008 – 2012

Figure 8 24: Rest of the World – Forecast for Other Companies Implantable Cardiac Pacemakers Revenue (Million US$), 2013 – 2017

Figure 9 1: Worldwide – Heart Valve Market (Million US$), 2009 – 2012

Figure 9 2: Worldwide – Forecast for Heart Valve Market (Million US$), 2013 – 2017

Figure 9 3: Worldwide – Heart Valve Sales Unit (Thousand), 2009 – 2012

Figure 9 4: Worldwide – Forecast for Heart Valve Sales Unit (Thousand), 2013 – 2017

Figure 9 5: Worldwide – Application wise Heart Valve Market Share (Percent), 2009 – 2012

Figure 9 6: Worldwide – Forecast for Application wise Heart Valve Market Share (Percent), 2013 – 2017

Figure 9 7: Worldwide – Companies wise Heart Valve Market Share (Percent), 2009 – 2012

Figure 9 8: Worldwide – Forecast for Companies wise Heart Valve Market Share (Percent), 2013 –2017

Figure 10 1: Worldwide – Transcatheter Heart Valve Market (Million US$), 2009 – 2012

Figure 10 2: Worldwide – Forecast for Transcatheter Heart Valve Market (Million US$), 2013 –2017

Figure 10 3: Worldwide – Transcatheter Heart Valve Sales Unit (Thousand), 2009 – 2012

Figure 10 4: Worldwide – Forecast for Transcatheter Heart Valve Sales Unit (Thousand), 2013 – 2017

Figure 10 5: Worldwide – Tissue Heart Valve Market (Million US$), 2009 – 2012

Figure 10 6: Worldwide – Forecast for Tissue Heart Valve Market (Million US$), 2013 – 2017

Figure 10 7: Worldwide – Tissue Heart Valve Sales Unit (Thousand), 2009 – 2012

Figure 10 8: Worldwide – Forecast for Tissue Heart Valve Sales Unit (Thousand), 2013 – 2017

Figure 10 9: Worldwide – Mechanical Heart Valves Market (Million US$), 2009 – 2012

Figure 10 10: Worldwide – Forecast for Mechanical Heart Valves Market (Million US$), 2013 – 2017

Figure 10 11: Worldwide – Mechanical Heart Valves Sales Unit (Thousand), 2009 – 2012

Figure 10 12: Worldwide – Forecast for Mechanical Heart Valves Sales Unit (Thousand), 2013 – 2017

Figure 10 13: Worldwide – Repair Heart Valve Market (Million US$), 2009 – 2012

Figure 10 14: Worldwide – Forecast for Repair Heart Valve Market (Million US$), 2013 – 2017

Figure 10 15: Worldwide – Repair Heart Valve Sales Unit (Thousand), 2009 – 2012

Figure 10 16: Worldwide – Forecast for Repair Heart Valve Sales Unit (Thousand), 2013 – 2017

Figure 10 17: Worldwide –Sutureless Heart Valve Market & Forecast (Million US$), 2012 – 2017

Figure 10 18: Worldwide – Sutureless Heart Valve Sales Unit & Forecast (Thousand), 2012 – 2017

Figure 11 1: Worldwide – Edwards Lifesciences Heart Valve Revenue (Million US$), 2009 – 2012

Figure 11 2: Worldwide – Forecast for Edwards Lifesciences Heart Valve Revenue (Million US$), 2013 – 2017

Figure 11 3: Worldwide – Medtronic Heart Valve Revenue (Million US$), 2009 – 2012

Figure 11 4: Worldwide – Forecast for Medtronic Heart Valve Revenue (Million US$), 2013 – 2017

Figure 11 5: Worldwide – St Jude Medical Heart Valve Revenue (Million US$), 2009 – 2012

Figure 11 6: Worldwide – Forecast for St Jude Heart Valve Revenue (Million US$), 2013 – 2017

Figure 11 7: Worldwide – Sorin Group Heart Valve Revenue (Million US$), 2009 – 2012

Figure 11 8: Worldwide – Forecast for Sorin Group Heart Valve Revenue (Million US$), 2013 – 2017

Figure 11 9: Worldwide – Other Companies Heart Valve Revenue (Million US$), 2009 – 2012

Figure 11 10: Worldwide – Forecast for Other Companies Heart Valve Revenue (Million US$), 2013 – 2017

Figure 12 1: Worldwide – Coronary Stent Market (Million US$), 2008 – 2012

Figure 12 2: Worldwide – Forecast for Coronary Stent Market (Million US$), 2013 – 2017

Figure 12 3: Worldwide – Coronary Stent Sales Unit (Thousand), 2008 – 2012

Figure 12 4: Worldwide – Forecast for Coronary Stent Sales Unit (Thousand), 2013 – 2017

Figure 12 5: Worldwide – Countries wise Coronary Stent Market Share (Percent), 2008 – 2012

Figure 12 6: Worldwide – Forecast for Countries wise Coronary Stent Market Share (Percent), 2013 – 2017

Figure 12 7: Worldwide – Segment wise Coronary Stent Market Share (Percent), 2008 – 2012

Figure 12 8: Worldwide – Forecast for Segment wise Coronary Stent Market Share (Percent), 2013 – 2017

Figure 12 9: Worldwide – Companies wise Coronary Stent Market Share (Percent), 2008 – 2012

Figure 12 10: Worldwide – Forecast for Companies wise Coronary Stent Market Share (Percent), 2013 – 2017

Figure 13 1: United States – Coronary Stent Market (Million US$), 2008 – 2012

Figure 13 2: United States – Forecast for Coronary Stent Market (Million US$), 2013 – 2017

Figure 13 3: United States – Coronary Stent Sales Unit (Thousand), 2008 – 2012

Figure 13 4: United States – Forecast for Coronary Stent Sales Unit (Thousand), 2013 – 2017

Figure 13 5: Europe & ROW – Coronary Stent Market (Million US$), 2008 – 2012

Figure 13 6: Europe & ROW – Forecast for Coronary Stent Market (Million US$), 2013 – 2017

Figure 13 7: Europe & ROW – Coronary Stent Sales Unit (Thousand), 2008 – 2012

Figure 13 8: Europe & ROW – Forecast for Coronary Stent Sales Unit (Thousand), 2013 – 2017

Figure 13 9: Japan – Coronary Stent Market (Million US$), 2008 – 2012

Figure 13 10: Japan – Forecast for Coronary Stent Market (Million US$), 2013 – 2017

Figure 13 11: Japan – Coronary Stent Sales Unit (Thousand), 2008 – 2012

Figure 13 12: Japan – Forecast for Coronary Stent Sales Unit (Thousand), 2013 – 2017

Figure 14 1: Worldwide – Drug Eluting Stent Market (Million US$), 2008 – 2012

Figure 14 2: Worldwide – Forecast for Drug Eluting Stent Market (Million US$), 2013 – 2017

Figure 14 3: United States – Drug Eluting Stent Market (Million US$), 2008 – 2012

Figure 14 4: United States – Forecast for Drug Eluting Stent Market (Million US$), 2013 – 2017

Figure 14 5: Europe & ROW – Drug Eluting Stent Market (Million US$), 2008 – 2012

Figure 14 6: Europe & ROW – Forecast for Drug Eluting Stent Market (Million US$), 2013 – 2017

Figure 14 7: Japan – Drug Eluting Stent Market (Million US$), 2008 – 2012

Figure 14 8: Japan – Forecast for Drug Eluting Stent Market (Million US$), 2013 – 2017

Figure 14 9: Worldwide – Drug Eluting Stent Sales Unit (Thousand), 2008 – 2012

Read the full report:

Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A

http://www.reportbuyer.com/pharma_healthcare/medical_devices/global_cardiac_bio_implant_devices_implantable_cardioverter_defibrillators_implantable_cardiac_pacemakers_heart_valve_coronary_stent_peripheral_stent_ventricular_assist_device_market_forecast_clinical_trials_ma.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices

For more information:

Sarah Smith

Research Advisor at Reportbuyer.com

Email: query@reportbuyer.com

Tel: +44 208 816 85 48

Website: http://www.reportbuyer.com

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/10/prweb11279727.htm


Source: prweb



comments powered by Disqus